< Back to latest news & events

Awards

IAM Strategy 300 2020

August 2020

IAM Strategy 300: The World’s Leading IP Strategists guide has now been published and HGF is proud to have 3 Partners listed.

IAM Strategy 300: The World’s Leading IP Strategists is IAM’s annual listing of individuals who lead the way in the development and implementation of world-class IP value creation programmes.

The guide identifies the world-class IP strategists who do not see issues from just one perspective; instead, they see value creation in the round. It is this 360-degree perspective, combined with a demonstrable ability to deliver, which makes them stand out from the crowd.

HGF has 3 Partners listed in the guide in 2020:

Dr Andrew Wells

Hsu Min Chung

For more information on the IAM Strategy 300 guide 2020 please click here.

Latest updates

Happy World IP Day!

This year’s theme is ‘IP and the SDGs: Building our common future with innovation and creativity’. At HGF we are committed to supporting our clients in sustainable technologies and routinely …

Read article

IP Ingredients, Part 12: Exploring colours in the food & drink sector – overcoming hurdles and leveraging colour trade marks

We will all recognise as consumers an instance of when we used the colour of a product or its packaging to identify a specific brand that we wanted to buy …

Read article

Medical 3D Technologies: From Scanning to Printing

When we think of 3D technologies, we often think of 3D printing, which, as discussed later, has seen rapid advances in recent years. However, a sometimes overlooked area of medical …

Read article

Opinion Piece: Unitary Patent and Unified Patent Court in Ireland

Intellectual Property (IP) is a core part of any business and particularly is a vital part of the strategic toolkit for any business that creates value through innovation and constant …

Read article

IP Ingredients Blog, Parts 11-20

Welcome to our blog series, IP Ingredients, created by our Food & Drink Team. This blog will explore the latest IP news, updates, and discussions in the food & drink …

Read article

EnteroBiotix Limited Secures £27m Financing Round to Advance Clinical Trials

We are pleased to congratulate EnteroBiotix, on their milestone in their journey towards revolutionising healthcare for patients battling gut-related ailments. The leading clinical-stage biotechnology company has successfully closed a £27 …

Read article